|
(3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methyl 2-((benzyloxy)carbonyl)amino-3-phenylpropanoate
|
C522269 |
|
|
CCA-binding oligopeptide 35
|
C561877 |
|
|
vinculin-activating peptide, Shigella flexneri
|
C561878 |
|
|
SH3-binding domain kinase 1, human
|
C561879 |
|
|
poly(N,N-diethylacrylamide-co-2-hydroxyethyl methacrylate)
|
C522270 |
|
|
(8'beta)-(3',4'-methylenedioxybenzyl)-gamma-butyrolactone
|
C522271 |
|
|
boroglycine
|
C522272 |
|
|
GNL1 protein, Arabidopsis
|
C522273 |
|
|
Cacng4 protein, rat
|
C522274 |
|
|
epipyridone
|
C522275 |
|
|
NUP98-NSD1 protein, human
|
C522276 |
|
|
Prescription Drug Monitoring Programs
|
D000073958 |
[Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.
] |
|
4-hydroxy-5-phenyl-6H-pyrido(3,2,1-jk)carbazol-6-one
|
C000601615 |
|
|
1,5-dimethoxynaphthalene
|
C000601616 |
|
|
poly(1,4-dihydroxyanthraquinoneimine-1,3-bis(phenylene-ester-methylene)tetramethyldisiloxane)
|
C000601617 |
|
|
Spinal muscular atrophy with respiratory distress 1
|
C536880 |
|
|
BTAF1 protein, mouse
|
C561880 |
|
|
Spinal muscular atrophy, Ryukyuan type
|
C536881 |
|
|
N-4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-ylthiophene-2-sulfonamide
|
C561881 |
|
|
ECB2 protein, Arabidopsis
|
C561882 |
|
